DNA synthesis inhibitors: Metronidazole

Last updated: June 18, 2025

DNA synthesis inhibitors: Metronidazole

Watch later

Watch later

Action potentials in myocytes
Action potentials in pacemaker cells
Excitability and refractory periods
Cardiac excitation-contraction coupling
Antidiuretic hormone
Calcitonin
Phosphate, calcium and magnesium homeostasis
Vitamin D
Blood components
Innate immune system
Complement system
Cytokines
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
B- and T-cell memory
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Bone remodeling and repair
Muscular system anatomy and physiology
Neuromuscular junction and motor unit
Slow twitch and fast twitch muscle fibers
Muscle spindles and golgi tendon organs
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Neuron action potential
Adrenergic receptors
Sympathetic nervous system
Parasympathetic nervous system
Cholinergic receptors
Body fluid compartments
Movement of water between body compartments
Hydration
Renin-angiotensin-aldosterone system
Sodium homeostasis
Potassium homeostasis
Osmoregulation
Necrosis and apoptosis
Hypoxia
Ischemia
Inflammation
Wound healing
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Pharmacodynamics: Drug-receptor interactions
Enzyme function
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Cholinomimetics: Direct agonists
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Anticoagulants: Heparin
Anticoagulants: Warfarin
Monoclonal antibodies
Glucocorticoids
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Antimetabolites: Sulfonamides and trimethoprim
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Protein synthesis inhibitors: Aminoglycosides
Miscellaneous cell wall synthesis inhibitors
Integrase and entry inhibitors
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Azoles
Miscellaneous antifungal medications
Echinocandins
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Parathyroid conditions and calcium imbalance: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
DNA replication
Transcription of DNA
DNA mutations
Translation of mRNA
Proteins
Resting membrane potential
Demyelinating disorders: Pathology review
Blood groups and transfusions
Microcirculation and Starling forces
Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus pneumoniae
Clostridium perfringens
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Clostridium difficile (Pseudomembranous colitis)
Escherichia coli
Salmonella (non-typhoidal)
Enterobacter
Shigella
Vibrio cholerae (Cholera)
Campylobacter jejuni
Mycoplasma pneumoniae
Viral structure and functions
Varicella zoster virus
Human herpesvirus 8 (Kaposi sarcoma)
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Human papillomavirus
Rhinovirus
Influenza virus
Norovirus
Rotavirus
Vaccinations
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Introduction to the lymphatic system
Mendelian genetics and punnett squares
Inheritance patterns
Muscular dystrophies and mitochondrial myopathies: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Independent assortment of genes and linkage
DNA structure
Nuclear structure
Amino acids and protein folding
Gene regulation
Lac operon
Karyotyping
Gel electrophoresis and genetic testing
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
DNA cloning
Down syndrome (Trisomy 21)
Huntington disease
Williams syndrome
Cystic fibrosis
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Immunodeficiencies: Clinical
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Dermatomyositis
Crohn disease
Complement deficiency
Lupus nephritis
Thymus histology
Lymph node histology
Spleen histology
Respiratory alkalosis

Transcript

Watch video only

DNA synthesis inhibitors are a group of antibiotics that target the synthesis of DNA in bacteria and other organisms. Metronidazole, a 5-nitroimidazole, prevents the synthesis of nucleic acids, which are the building blocks of DNA, and is effective against many bacteria and protozoans.

Metronidazole and related 5-nitroimidazoles are relatively nontoxic to humans. This is because in order to function, they need to be reduced by a protein called ferredoxin, which contains sulfur and iron. This protein is commonly found in anaerobic bacteria and protozoans, but is not as available in humans and aerobic bacteria. Now, this protein can donate an electron to metronidazole, causing it to form free radicals which will damage the DNA, causing it to fragment. Without the DNA as a template, the organism can’t synthesize any more nucleic acids like DNA or mRNA, which will lead to cell death.

Metronidazole can be taken orally, but it’s also available in an IV form and as topical creams. It penetrates well into body tissues and fluids, including vaginal secretions, seminal fluid, saliva, breast milk, cerebrospinal fluid, and crosses over the placenta.

This medication can treat many anaerobic bacterial infections like Clostridioides difficile, which can cause pseudomembranous enterocolitis in people taking other antibiotics. Another common organism treated by this medication is Helicobacter pylori, a common bacteria that causes gastritis and peptic ulcers. However, it should be used in combination with other antimicrobials and proton pump inhibitors as part of a triple therapy for the best outcome when treating this condition. Next, Gardnerella vaginalis and other anaerobes that can cause bacterial vaginosis are all treated by metronidazole.

For protozoan infections, it’s the medication of choice for amoebiasis, an infection of the gut caused by Entamoeba histolytica. It’s the medication of choice against Trichomonas vaginalis as well, which causes vaginal trichomoniasis. Finally, metronidazole is highly effective against giardiasis, or beaver fever, which is an infection of the gut caused by Giardia lamblia.

Metronidazole is metabolized in the liver and it’s an inhibitor of CYP450 enzymes, so it can slow down the metabolism of other medications, like warfarin, which are also broken down by this enzyme.

Common side effects of metronidazole include decreased appetite, nausea, a metallic taste in the mouth, headaches, and stomach cramps.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review, 12th ed. © (ISBN-13: 978-1259641022) " Katzung (2018 )
  2. "Rang & Dale’s Pharmacology, 9th ed,. © (ISBN-13: 978-0702074486) " Ritter (2019 )
  3. "Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 13th ed. (ISBN-13: 978-1259584732 " Brunton
  4. "Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). 66(7), e1-e48. " Clinical Infectious Diseases (2018)
  5. "Bacterial Vaginosis: Review of Treatment Options and Potential Clinical Indications for Therapy. 28(s1), S57-S65. " Clinical Infectious Diseases (1999)
  6. "Sudden Death Due to Metronidazole/Ethanol Interaction. 17(4), 343-346." The American Journal of Forensic Medicine and Pathology (1996)
  7. "A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity. 45(3), 302-307. " Clinical Infectious Diseases (2007)
  8. "Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action. Journal of Antimicrobial 31(1), 9-20. " Chemotherapy (1993)